Quick Takeaways
- Xiaolin Wang has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $11,545,993.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Xiaolin Wang
- Location
- Redwood City, CA
- Summary
- The estimated net worth of Xiaolin Wang is at least $11,545,993 dollars as of 19 Mar 2026. Xiaolin Wang is the EVP, Clinical Development of Revolution Medicines, Inc. and owns shares of Revolution Medicines, Inc. (RVMD) stock worth about $11.55M.
- Signature
- /s/ Jack Anders, as Attorney-in-fact for Xiaolin Wang
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Xiaolin Wang and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Revolution Medicines, Inc. ($11,545,993).
- Past-year value change for that position: -$199,956.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Xiaolin Wang
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RVMD, RVMDW | Revolution Medicines, Inc. | EVP, Clinical Development | $11,545,993 | -$199,956 | -1.7% | 17 Mar 2026 |
Insider Transactions Reported by Xiaolin Wang:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.